Company Overview of OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc., an ophthalmic pharmaceutical company, develops topical eye drops for the treatment of age-related macular degeneration and diabetic retinopathy diseases. The company was founded in 2005 and is based in Roanoke, Virginia.
15 East Salem Avenue
Roanoke, VA 24011
Founded in 2005
Key Executives for OcuCure Therapeutics, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
March 14, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact OcuCure Therapeutics, Inc., please visit www.ocucure.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.